Market Place
Sourcing Support
Lupin launches Bumetanide Injection USP in US
20 Nov 2024 //
PRESS RELEASE
Qilu Pharma`s Generics Bumetanide Receives Approval in US
19 Sep 2024 //
FDA
Lupin gets US FDA nod for Bumetanide Injection, USP
19 Sep 2024 //
EXPRESSPHARMA
Appco`s Generics Bumetanide Receives Approval in US
18 Sep 2024 //
FDA
Glenmark Pharma launches Bumetanide Injection USP, 1 mg/4 mL & 2.5 mg/10 mL
10 Jan 2023 //
PR NEWSWIRE
Glenmark Pharma launches generic version of diuretic Bumetanide injection
10 Jan 2023 //
ECONOMIC TIMES
MSN`s Generic Bumetanide Receives Approval in the U.S.
04 Aug 2022 //
FDA
NIH Believes Common Diuretic Drug Could Lower Risk of Alzheimer`s
12 Oct 2021 //
BIOSPACE
Mouse experiments with a decades-old drug hint a new Alzheimer’s treatment
11 Oct 2021 //
STATNEWS
Servier & Neurochlore announce main results of the two phase 3 clinical studies
07 Sep 2021 //
PRNEWSWIRE
Enforcement Report - Week of October 31, 2018
31 Oct 2018 //
FDA
FDA Singles Out Three Drug Substances to Not be Compounded
27 Aug 2018 //
RAPS
Upsher-Smith Receives FDA Approval For Bumetanide Tablets, USP
30 Jan 2018 //
PR NEWSWIRE
Amneal Pharm’s Generic Bumetanide Receives Approval In US
23 Oct 2017 //
FDA
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.